Juan Mucci

Dr. Juan Mucci


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2013 in Nature Immunology
Verified
Journal Article
Open access
PDF file
DBDaniela A Bermejo
Daniela A Bermejo
SJShaun W Jackson
Shaun W Jackson
MGMelisa Gorosito-Serran
Melisa Gorosito-Serran
EREva Acosta Rodriguez
Eva Acosta Rodriguez
MAMaria C Amezcua-Vesely
Maria C Amezcua-Vesely
DRDavid J Rawlings
David J Rawlings
Antibody production is the main effector function of B cells. Rawlings and colleagues show that Trypanosome cruzi induces rapid IL-17 production by B cells that is required for parasite control. Here we identified B cells as a major source of rapid, innate-like production of interleukin 17 (IL-17) in vivo in response to infection with Trypanosoma cruzi. IL-17+ B cells had a plasmablast phenotype, outnumbered cells of the TH17 subset of helper T cells and were required for an optimal response to this pathogen. With both mouse and human primary B cells, we found that exposure to parasite-derived trans-sialidase in vitro was sufficient to trigger modification of the cell-surface mucin CD45, which led to signaling dependent on the kinase Btk and production of IL-17A or IL-17F via a transcriptional program independent of the transcription factors RORγt and Ahr. Our combined data suggest that the generation of IL-17+ B cells may be a previously unappreciated feature of innate immune responses required for pathogen control or IL-17-mediated autoimmunity.

12 March 2002 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
JMJuan Mucci
Juan Mucci
AHAlejandra Hidalgo
Alejandra Hidalgo
EMEsteban Mocetti
Esteban Mocetti
PAPablo F. Argibay
Pablo F. Argibay
MLM. Susana Leguizamón
M. Susana Leguizamón
OCOscar Campetella
Oscar Campetella
Trypanosoma cruzi , the causative agent of Chagas' disease, induces transient thymic aplasia early after infection—a phenomenon that stills lacks a molecular explanation. The parasite sheds an enzyme known as trans -sialidase (TS), which is able to direct transfer-sialyl residues among macromolecules. Because cell-surface sialylation is known to play a central role in the immune system, we tested whether the bloodstream-borne TS is responsible for the thymic alterations recorded during infection. We found that recombinant TS administered to naive mice was able to induce cell-count reduction mediated by apoptosis, mimicking cell subsets distribution and histologic findings observed during the acute phase of the infection. Thymocytes taken after TS treatment showed low response to Con A, although full ability to respond to IL-2 or IL-2 plus Con A was conserved, which resembles findings from infected animals. Alterations were found to revert several days after TS treatment. The administration of TS-neutralizing Abs to T. cruzi -infected mice prevented thymus alterations. Results indicate that the primary target for the TS-induced apoptosis is the so-called “nurse cell complex”. Therefore, we report here supporting evidence that TS is the virulence factor from T. cruzi responsible for the thymic alterations via apoptosis induction on the nurse cell complex, and that TS-neutralizing Abs elicitation during infection is associated with the reversion to thymic normal parameters.

24 September 2007 in Glycobiology
Verified
Journal Article
Closed access
PDF file
MTMaría Virginia Tribulatti
María Virginia Tribulatti
JMJuan Mucci
Juan Mucci
VCValentina Cattaneo
Valentina Cattaneo
FAFernán Agüero
Fernán Agüero
TGTim Gilmartin
Tim Gilmartin
OCOscar Campetella
Oscar Campetella
In the present work, we followed a microarray approach to analyze the expression of glycosylation-related genes on different cell populations obtained from mouse thymus. Among other genes, transcription of the two-domain type galectin-8 was detected both in thymocytes and thymic epithelial cells (TECs), which was confirmed by reverse transcriptase (RT)-PCR assays independently carried out on both cell populations. Two splice variants, differing solely in the presence of a nine amino acid insertion in the linker peptide region connecting the two carbohydrate recognition domains (CRDs), were identified from purified thymocytes. Expression of galectin-8 was verified at the protein level in total organ extracts by western-blots of lactosyl-Sepharose purified binders. To explore the possible biological roles of locally produced galectin-8, both splice variants were recombinantly expressed in bacteria and assayed over cultured thymocytes. In spite of their binding to all cell populations, addition of either isoform of galectin-8 to thymocyte cultures induced apoptosis only of the CD4highCD8high cells through caspases pathway activation. All of these effects were prevented by the addition of thiodigalactoside (TDG) or lactose, thus indicating that the proapoptotic activity of galectin-8 was due to the specific interaction of its CRDs with defined cell surface glycans. Together, our results demonstrate intrathymic expression of galectin-8 in mouse, and suggest an active role for this lectin in shaping the mature T cell repertoire.

1 July 2015 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
SCSantiago J. Carmona
Santiago J. Carmona
MNMorten Nielsen
Morten Nielsen
CSClaus Schafer-Nielsen
Claus Schafer-Nielsen
JMJuan Mucci
Juan Mucci
JAJaime Altcheh
Jaime Altcheh
FAFernán Agiero
Fernán Agiero
Complete characterization of antibody specificities associated to natural infections is expected to provide a rich source of serologic biomarkers with potential applications in molecular diagnosis, follow-up of chemotherapeutic treatments, and prioritization of targets for vaccine development. Here, we developed a highly-multiplexed platform based on next-generation high-density peptide microarrays to map these specificities in Chagas Disease, an exemplar of a human infectious disease caused by the protozoan Trypanosoma cruzi. We designed a high-density peptide microarray containing more than 175,000 overlapping 15mer peptides derived from T. cruzi proteins. Peptides were synthesized in situ on microarray slides, spanning the complete length of 457 parasite proteins with fully overlapped 15mers (1 residue shift). Screening of these slides with antibodies purified from infected patients and healthy donors demonstrated both a high technical reproducibility as well as epitope mapping consistency when compared with earlier low-throughput technologies. Using a conservative signal threshold to classify positive (reactive) peptides we identified 2,031 disease-specific peptides and 97 novel parasite antigens, effectively doubling the number of known antigens and providing a 10-fold increase in the number of fine mapped antigenic determinants for this disease. Finally, further analysis of the chip data showed that optimizing the amount of sequence overlap of displayed peptides can increase the protein space covered in a single chip by at least ∼threefold without sacrificing sensitivity. In conclusion, we show the power of high-density peptide chips for the discovery of pathogen-specific linear B-cell epitopes from clinical samples, thus setting the stage for high-throughput biomarker discovery screenings and proteome-wide studies of immune responses against pathogens.

1 January 2005 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
MTMaría Virginia Tribulatti
María Virginia Tribulatti
JMJuan Mucci
Juan Mucci
NRNico Van Rooijen
Nico Van Rooijen
MLMaría Susana Leguizamón
María Susana Leguizamón
OCOscar Campetella
Oscar Campetella
Strong thrombocytopenia is observed during acute infection with Trypanosoma cruzi , the parasitic protozoan agent of American trypanosomiasis or Chagas' disease. The parasite sheds trans -sialidase, an enzyme able to mobilize the sialyl residues on cell surfaces, which is distributed in blood and is a virulence factor. Since the sialic acid content on the platelet surface is crucial for determining the half-life of platelets in blood, we examined the possible involvement of the parasite-derived enzyme in thrombocytopenia induction. We found that a single intravenous injection of trans -sialidase into naïve mice reduced the platelet count by 50%, a transient effect that lasted as long as the enzyme remained in the blood. CD43 −/− mice were affected to a similar extent. When green fluorescent protein-expressing platelets were treated in vitro with trans -sialidase, their sialic acid content was reduced together with their life span, as determined after transfusion into naïve animals. No apparent deleterious effect on the bone marrow was observed. A central role for Kupffer cells in the clearance of trans -sialidase-altered platelets was revealed after phagocyte depletion by administration of clodronate-containing liposomes and splenectomy. Consistent with this, parasite strains known to exhibit more trans -sialidase activity induced heavier thrombocytopenia. Finally, the passive transfer of a trans -sialidase-neutralizing monoclonal antibody to infected animals prevented the clearance of transfused platelets. Results reported here strongly support the hypothesis that the trans -sialidase is the virulence factor that, after depleting the sialic acid content of platelets, induces the accelerated clearance of the platelets that leads to the thrombocytopenia observed during acute Chagas' disease.

13 February 2006 in Cellular Microbiology
Verified
Journal Article
Open access
PDF file
JMJuan Mucci
Juan Mucci
MRMarikena G. Risso
Marikena G. Risso
MLM. Susana Leguizamon
M. Susana Leguizamon
AFAlberto C. C. Frasch
Alberto C. C. Frasch
OCOscar Campetella
Oscar Campetella
The trans-sialidase, a modified sialidase that transfers sialyl residues among macromolecules, is a unique enzymatic activity expressed by some parasitic trypanosomes being essential for their survival in the mammalian host and/or in the insect vector. The enzyme from Trypanosoma cruzi, the agent of Chagas disease, is found in blood and able to act far from the infection site by inducing apoptosis in cells from the immune system. A central and still unsolved question is whether trans-sialidase-mediated addition or removal of sialic acid to/from host acceptor molecules is the event associated with the apoptosis induced by the enzyme. Here we show that lactitol, a competitive inhibitor that precluded the transference of the sialyl residue to endogenous acceptors but not the hydrolase activity of the enzyme, prevented ex vivo and in vivo the apoptosis caused by the trans-sialidase. By lectin histochemistry, the transference of sialyl residue to the cell surface was demonstrated in vivo and found associated with the apoptosis induction. The sialylation of the CD43 mucin, a key molecule involved in trans-sialidase-apoptotic process, was readily detected and also prevented by lactitol on thymocytes. Therefore, lesions induced by trans-sialidase on the immune system are due to the sialylation of endogenous acceptor molecules.